isoproterenol has been researched along with ginsenoside rg2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, WF; Li, H; Li, LY; Tian, JM; Wang, LP; Ye, JM | 1 |
| Fu, W; Sui, D; Wang, Q; Wang, Y; Xu, H; Yu, X | 1 |
2 other study(ies) available for isoproterenol and ginsenoside rg2
| Article | Year |
|---|---|
[Effect of ginsenoside Rg2 on chemical myocardial ischemia in rats].
Topics: Animals; Creatine Kinase; Electrocardiography; Female; Ginsenosides; Isoproterenol; Male; Malondialdehyde; Myocardial Ischemia; Myocardium; Panax; Pituitary Hormones, Posterior; Plant Leaves; Plants, Medicinal; Rats; Rats, Wistar; Sodium Nitrite; Superoxide Dismutase | 2003 |
Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Fibrosis; Ginsenosides; Isoproterenol; Male; Myocardial Ischemia; Panax; Rats; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2021 |